Concepts (144)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Deglutition Disorders | 9 | 2020 | 297 | 3.630 |
Why?
|
| Aphasia | 8 | 2022 | 119 | 3.270 |
Why?
|
| Stroke | 15 | 2022 | 2161 | 3.000 |
Why?
|
| Gastrostomy | 4 | 2017 | 110 | 2.140 |
Why?
|
| Enteral Nutrition | 4 | 2019 | 157 | 2.140 |
Why?
|
| Stroke Rehabilitation | 4 | 2021 | 334 | 1.640 |
Why?
|
| Speech | 3 | 2019 | 118 | 1.450 |
Why?
|
| Brain | 9 | 2022 | 2175 | 1.430 |
Why?
|
| Nerve Net | 2 | 2021 | 180 | 1.390 |
Why?
|
| Gastroscopy | 2 | 2016 | 45 | 1.130 |
Why?
|
| Device Removal | 2 | 2017 | 100 | 1.090 |
Why?
|
| Deglutition | 5 | 2020 | 221 | 1.020 |
Why?
|
| Language | 4 | 2022 | 120 | 0.900 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 4 | 2021 | 239 | 0.900 |
Why?
|
| White Matter | 3 | 2021 | 174 | 0.820 |
Why?
|
| Recovery of Function | 3 | 2021 | 506 | 0.810 |
Why?
|
| Connectome | 4 | 2022 | 91 | 0.740 |
Why?
|
| Leukoencephalopathies | 1 | 2019 | 13 | 0.720 |
Why?
|
| Cerebral Ventricles | 1 | 2019 | 36 | 0.710 |
Why?
|
| Transcranial Direct Current Stimulation | 1 | 2021 | 111 | 0.690 |
Why?
|
| Retrospective Studies | 15 | 2022 | 7264 | 0.670 |
Why?
|
| Eating | 1 | 2019 | 119 | 0.660 |
Why?
|
| Brain Injuries | 1 | 2021 | 268 | 0.650 |
Why?
|
| Middle Aged | 20 | 2022 | 21119 | 0.640 |
Why?
|
| Dominance, Cerebral | 1 | 2018 | 65 | 0.640 |
Why?
|
| Weights and Measures | 1 | 2017 | 5 | 0.630 |
Why?
|
| Magnetic Resonance Imaging | 10 | 2022 | 2222 | 0.630 |
Why?
|
| Aged | 17 | 2022 | 14842 | 0.620 |
Why?
|
| Adult | 18 | 2022 | 21375 | 0.560 |
Why?
|
| Feeding and Eating Disorders | 1 | 2017 | 106 | 0.550 |
Why?
|
| Disability Evaluation | 1 | 2017 | 298 | 0.540 |
Why?
|
| Guideline Adherence | 1 | 2016 | 284 | 0.480 |
Why?
|
| Humans | 31 | 2022 | 68525 | 0.480 |
Why?
|
| Patient Readmission | 1 | 2016 | 267 | 0.470 |
Why?
|
| Male | 21 | 2022 | 37281 | 0.460 |
Why?
|
| Sepsis | 1 | 2016 | 233 | 0.460 |
Why?
|
| Female | 20 | 2022 | 38015 | 0.450 |
Why?
|
| Aged, 80 and over | 7 | 2019 | 4843 | 0.450 |
Why?
|
| Brain Ischemia | 1 | 2019 | 665 | 0.450 |
Why?
|
| Brain Mapping | 5 | 2022 | 531 | 0.430 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2016 | 503 | 0.410 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 772 | 0.400 |
Why?
|
| Radiation Dosage | 5 | 2021 | 419 | 0.380 |
Why?
|
| Barium | 3 | 2021 | 52 | 0.380 |
Why?
|
| Neural Pathways | 2 | 2021 | 323 | 0.350 |
Why?
|
| Surveys and Questionnaires | 1 | 2017 | 2798 | 0.350 |
Why?
|
| Barium Sulfate | 2 | 2021 | 66 | 0.340 |
Why?
|
| Axons | 2 | 2021 | 139 | 0.340 |
Why?
|
| Radiation Exposure | 2 | 2021 | 84 | 0.340 |
Why?
|
| Electroencephalography | 2 | 2021 | 418 | 0.310 |
Why?
|
| Patient Discharge | 3 | 2019 | 294 | 0.300 |
Why?
|
| Florida | 2 | 2016 | 221 | 0.270 |
Why?
|
| Fluoroscopy | 4 | 2021 | 152 | 0.270 |
Why?
|
| Databases, Factual | 3 | 2017 | 621 | 0.260 |
Why?
|
| Contrast Media | 2 | 2019 | 594 | 0.250 |
Why?
|
| Time Factors | 3 | 2019 | 4655 | 0.250 |
Why?
|
| Reproducibility of Results | 3 | 2019 | 2077 | 0.240 |
Why?
|
| Multivariate Analysis | 2 | 2016 | 1046 | 0.230 |
Why?
|
| Language Disorders | 1 | 2022 | 22 | 0.220 |
Why?
|
| Logistic Models | 2 | 2016 | 1419 | 0.210 |
Why?
|
| Bronchiectasis | 1 | 2021 | 25 | 0.200 |
Why?
|
| Drug Resistant Epilepsy | 1 | 2021 | 44 | 0.200 |
Why?
|
| Photic Stimulation | 1 | 2021 | 229 | 0.200 |
Why?
|
| Acoustic Stimulation | 1 | 2021 | 206 | 0.200 |
Why?
|
| Mycobacterium Infections, Nontuberculous | 1 | 2021 | 37 | 0.190 |
Why?
|
| Radiometry | 2 | 2018 | 64 | 0.190 |
Why?
|
| Pharynx | 2 | 2018 | 89 | 0.190 |
Why?
|
| Temporal Lobe | 1 | 2021 | 125 | 0.190 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2021 | 211 | 0.180 |
Why?
|
| Aphasia, Broca | 1 | 2019 | 11 | 0.180 |
Why?
|
| Leukoaraiosis | 1 | 2019 | 14 | 0.180 |
Why?
|
| Speech Production Measurement | 1 | 2019 | 14 | 0.180 |
Why?
|
| Lung Diseases | 1 | 2021 | 175 | 0.180 |
Why?
|
| Cineradiography | 1 | 2019 | 12 | 0.180 |
Why?
|
| Nerve Fibers | 1 | 2019 | 77 | 0.180 |
Why?
|
| Longitudinal Studies | 2 | 2021 | 1054 | 0.170 |
Why?
|
| Brain Diseases | 1 | 2019 | 78 | 0.170 |
Why?
|
| Speech-Language Pathology | 1 | 2019 | 24 | 0.170 |
Why?
|
| Fibroblast Growth Factors | 1 | 2018 | 51 | 0.160 |
Why?
|
| Thyroid Gland | 1 | 2018 | 67 | 0.160 |
Why?
|
| Case-Control Studies | 2 | 2021 | 1548 | 0.160 |
Why?
|
| Larynx | 1 | 2018 | 49 | 0.160 |
Why?
|
| Risk Adjustment | 1 | 2017 | 49 | 0.150 |
Why?
|
| Axis, Cervical Vertebra | 1 | 2017 | 5 | 0.150 |
Why?
|
| Parkinson Disease | 1 | 2020 | 272 | 0.150 |
Why?
|
| Diskectomy | 1 | 2017 | 12 | 0.150 |
Why?
|
| Frontal Lobe | 1 | 2018 | 156 | 0.150 |
Why?
|
| Epilepsy | 1 | 2021 | 336 | 0.150 |
Why?
|
| Administrative Claims, Healthcare | 1 | 2016 | 7 | 0.150 |
Why?
|
| Skilled Nursing Facilities | 1 | 2016 | 30 | 0.140 |
Why?
|
| Spinal Fusion | 1 | 2017 | 90 | 0.140 |
Why?
|
| Chronic Disease | 1 | 2021 | 1329 | 0.140 |
Why?
|
| Treatment Outcome | 2 | 2019 | 7028 | 0.130 |
Why?
|
| Self Report | 1 | 2017 | 370 | 0.130 |
Why?
|
| Evidence-Based Practice | 1 | 2017 | 146 | 0.130 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 2264 | 0.130 |
Why?
|
| Inpatients | 1 | 2017 | 208 | 0.130 |
Why?
|
| Time-to-Treatment | 1 | 2016 | 117 | 0.130 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 546 | 0.130 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 3256 | 0.130 |
Why?
|
| Odds Ratio | 1 | 2016 | 880 | 0.120 |
Why?
|
| Risk Assessment | 2 | 2019 | 2004 | 0.120 |
Why?
|
| Aging | 1 | 2019 | 911 | 0.110 |
Why?
|
| Length of Stay | 1 | 2016 | 780 | 0.110 |
Why?
|
| Comorbidity | 1 | 2017 | 1425 | 0.110 |
Why?
|
| Cohort Studies | 3 | 2022 | 2356 | 0.100 |
Why?
|
| Risk Factors | 2 | 2018 | 5719 | 0.090 |
Why?
|
| Postoperative Complications | 1 | 2017 | 1615 | 0.090 |
Why?
|
| Adolescent | 4 | 2022 | 8903 | 0.080 |
Why?
|
| Monte Carlo Method | 2 | 2018 | 124 | 0.080 |
Why?
|
| Child | 3 | 2021 | 6400 | 0.060 |
Why?
|
| Infant | 2 | 2021 | 2891 | 0.060 |
Why?
|
| Language Tests | 1 | 2022 | 36 | 0.060 |
Why?
|
| Semantics | 1 | 2022 | 37 | 0.050 |
Why?
|
| Psycholinguistics | 1 | 2021 | 10 | 0.050 |
Why?
|
| Asymptomatic Infections | 1 | 2021 | 6 | 0.050 |
Why?
|
| Nontuberculous Mycobacteria | 1 | 2021 | 22 | 0.050 |
Why?
|
| Scalp | 1 | 2021 | 47 | 0.050 |
Why?
|
| Electrodes | 1 | 2021 | 147 | 0.050 |
Why?
|
| Forecasting | 1 | 2021 | 277 | 0.040 |
Why?
|
| Seizures | 1 | 2021 | 279 | 0.040 |
Why?
|
| Young Adult | 2 | 2021 | 5708 | 0.040 |
Why?
|
| Statistics, Nonparametric | 1 | 2019 | 306 | 0.040 |
Why?
|
| Vascular Stiffness | 1 | 2018 | 31 | 0.040 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2019 | 79 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2020 | 517 | 0.040 |
Why?
|
| Cerebral Cortex | 1 | 2021 | 415 | 0.040 |
Why?
|
| Hyoid Bone | 1 | 2017 | 10 | 0.040 |
Why?
|
| Vascular Calcification | 1 | 2018 | 131 | 0.040 |
Why?
|
| Endothelium, Vascular | 1 | 2018 | 371 | 0.040 |
Why?
|
| Lung | 1 | 2021 | 849 | 0.040 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2018 | 161 | 0.040 |
Why?
|
| Observer Variation | 1 | 2017 | 330 | 0.040 |
Why?
|
| Video Recording | 1 | 2017 | 145 | 0.030 |
Why?
|
| Software | 1 | 2018 | 418 | 0.030 |
Why?
|
| Medicare | 1 | 2017 | 316 | 0.030 |
Why?
|
| Sex Factors | 1 | 2019 | 1265 | 0.030 |
Why?
|
| Incidence | 1 | 2019 | 1582 | 0.030 |
Why?
|
| Age Factors | 1 | 2019 | 1860 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2017 | 866 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2018 | 2453 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 2323 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 938 | 0.020 |
Why?
|
| United States | 1 | 2017 | 7335 | 0.020 |
Why?
|